These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 17318442)
21. Determination of unbound prednisolone, prednisone and cortisol in human serum and saliva by on-line solid-phase extraction liquid chromatography tandem mass spectrometry and potential implications for drug monitoring of prednisolone and prednisone in saliva. Ruiter AF; Teeninga N; Nauta J; Endert E; Ackermans MT Biomed Chromatogr; 2012 Jul; 26(7):789-96. PubMed ID: 22020542 [TBL] [Abstract][Full Text] [Related]
22. Simultaneous determination of prednisolone, prednisone, cortisol, and cortisone in plasma by GC-MS: estimating unbound prednisolone concentration in patients with nephrotic syndrome during oral prednisolone therapy. Shibasaki H; Nakayama H; Furuta T; Kasuya Y; Tsuchiya M; Soejima A; Yamada A; Nagasawa T J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):164-9. PubMed ID: 18387858 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic interaction between endogenous cortisol and exogenous corticosteroids. Rohatagi S; Hochhaus G; Möllmann H; Barth J; Derendorf H Pharmazie; 1995 Sep; 50(9):610-3. PubMed ID: 7480097 [TBL] [Abstract][Full Text] [Related]
25. Simultaneous measurement of prednisone, prednisolone and hydrocortisone in plasma by high performance liquid chromatography. Alvinerie M; Sutra JF; Galtier P; Houin G; Toutain PL Ann Biol Clin (Paris); 1990; 48(2):87-90. PubMed ID: 2344076 [TBL] [Abstract][Full Text] [Related]
26. Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects. Lebrun-Vignes B; Archer VC; Diquet B; Levron JC; Chosidow O; Puech AJ; Warot D Br J Clin Pharmacol; 2001 May; 51(5):443-50. PubMed ID: 11422002 [TBL] [Abstract][Full Text] [Related]
27. Tear Fluid Pharmacokinetics Following Oral Prednisone Administration in Dogs With and Without Conjunctivitis. Sebbag L; Yan Y; Smith JS; Allbaugh RA; Wulf LW; Mochel JP J Ocul Pharmacol Ther; 2019; 35(6):341-349. PubMed ID: 31070497 [No Abstract] [Full Text] [Related]
28. Pharmacokinetic/pharmacodynamic modelling of effects of dexamethasone and prednisolone in combination with endogenous cortisol on lymphocyte counts and systemic markers of bone turn over and inflammation in healthy and asthmatic men. Dubois EF; Derks MG; Schweitzer DH; Zwinderman AH; Dekhuijzen PN; van Boxtel CJ Eur J Clin Pharmacol; 2004 Jul; 60(5):315-28. PubMed ID: 15150679 [TBL] [Abstract][Full Text] [Related]
30. Predicting Cortisol Exposure from Paediatric Hydrocortisone Formulation Using a Semi-Mechanistic Pharmacokinetic Model Established in Healthy Adults. Melin J; Parra-Guillen ZP; Hartung N; Huisinga W; Ross RJ; Whitaker MJ; Kloft C Clin Pharmacokinet; 2018 Apr; 57(4):515-527. PubMed ID: 28762136 [TBL] [Abstract][Full Text] [Related]
31. Lack of pharmacokinetic and pharmacodynamic interactions between ketoconazole and prednisolone. Yamashita SK; Ludwig EA; Middleton E; Jusko WJ Clin Pharmacol Ther; 1991 May; 49(5):558-70. PubMed ID: 1827622 [TBL] [Abstract][Full Text] [Related]
32. Simultaneous determination of prednisone, prednisolone, cortisol and dexamethasone in plasma by high-performance liquid chromatography. Lasić S; Bobarević N; Nikolin B J Pharm Biomed Anal; 1989; 7(6):777-82. PubMed ID: 2490780 [No Abstract] [Full Text] [Related]
33. Pharmacokinetic/pharmacodynamic evaluation of deflazacort in comparison to methylprednisolone and prednisolone. Möllmann H; Hochhaus G; Rohatagi S; Barth J; Derendorf H Pharm Res; 1995 Jul; 12(7):1096-100. PubMed ID: 7494809 [TBL] [Abstract][Full Text] [Related]
34. Prednisone and prednisolone interconversion in the rabbit utilizing unbound concentrations. Hammarlund-Udenaes M; Benet LZ Biopharm Drug Dispos; 1991; 12(6):467-77. PubMed ID: 1932610 [TBL] [Abstract][Full Text] [Related]
35. Mechanism-based PK/PD model for the lymphocytopenia induced by endogenous and exogenous corticosteroids. Meibohm B; Derendorf H; Möllmann H; Fröhlich P; Tromm A; Wagner M; Homrighausen S; Krieg M; Hochhaus G Int J Clin Pharmacol Ther; 1999 Aug; 37(8):367-76. PubMed ID: 10475139 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic/pharmacodynamic modeling of cortisol suppression after oral administration of fluocortolone. Rohatagi S; Täuber U; Richter K; Derendorf H J Clin Pharmacol; 1996 Apr; 36(4):311-4. PubMed ID: 8728344 [TBL] [Abstract][Full Text] [Related]
37. Suppression of human monocyte tumour necrosis factor-alpha release by glucocorticoid therapy: relationship to systemic monocytopaenia and cortisol suppression. Steer JH; Vuong Q; Joyce DA Br J Clin Pharmacol; 1997 Apr; 43(4):383-9. PubMed ID: 9146850 [TBL] [Abstract][Full Text] [Related]
38. Effect of an oral contraceptive on the plasma levels of budesonide and prednisolone and the influence on plasma cortisol. Seidegård J; Simonsson M; Edsbäcker S Clin Pharmacol Ther; 2000 Apr; 67(4):373-81. PubMed ID: 10801246 [TBL] [Abstract][Full Text] [Related]
39. Plasma protein binding interaction of prednisone and prednisolone. Boudinot FD; Jusko WJ J Steroid Biochem; 1984 Sep; 21(3):337-9. PubMed ID: 6492791 [TBL] [Abstract][Full Text] [Related]
40. Determination of the glucocorticoids prednisone, prednisolone, dexamethasone, and cortisol in human serum using liquid chromatography coupled to tandem mass spectrometry. Frerichs VA; Tornatore KM J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Apr; 802(2):329-38. PubMed ID: 15018795 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]